Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DPY19L2 (Probable C-mannosyltransferase DPY19L2) is a transmembrane glycosyltransferase enzyme highly expressed in the testis, where it is essential for the development of the acrosome and elongation of the sperm head during spermatogenesis[1][4][6]. The protein localizes to the inner nuclear membrane of round spermatids and anchors the developing acrosome to the nuclear envelope, a critical step in normal sperm morphogenesis[3][4]. Mutations or deletions in the DPY19L2 gene result in globozoospermia, characterized by round-headed sperm cells lacking an acrosome, which causes male infertility[1][2][4][6]. DPY19L2 has mannosyltransferase activity and attaches mannose to tryptophan residues of substrate proteins, a process called C-mannosylation[3][6]. There are no known therapeutic drugs targeting DPY19L2 as of now, and its principal biomedical relevance lies in its role in genetic infertility diagnosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Probable C-mannosyltransferase DPY19L2 (DPY19L2).